Crossmark

Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice

Published Online: 2021-10-30

Published Print: 2021-12

Authors

Weichseldorfer, Matthew

Affram, Yvonne

Heredia, Alonso

Rikhtegaran-Tehrani, Zahra

Sajadi, Mohammad M.

Williams, Sumiko P.

Tagaya, Yutaka

Benedetti, Francesca

Ramadhani, Habib O.

Denaro, Frank

Munawwar, Arshi

Bryant, Joseph

Zella, Davide

Reitz, Marvin

Romerio, Fabio

Latinovic, Olga S.
License Information

Text and Data Mining valid from 2021-10-30

Version of Record valid from 2021-10-30
More Information

Article History

Received: 20 September 2021

Accepted: 16 October 2021

First Online: 30 October 2021

Declarations

:

: Animals were housed under pathogen-free conditions at the IHV Animal Facility, School of Medicine, University of Maryland (SOM UM) (Baltimore, MD). All experimental protocols were in accordance with the NIH guide for the care and use of laboratory animals and approved (Protocol #1215007) by the SOM UM IACUC.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current